Variables | LVH+ n = 231 | LVH− n = 182 | p |
Age, year | 52.9 ± 12.8 | 48.7 ± 9.4 | <0.001 |
Age ≥ 55 years | 91 (39.4) | 42 (23.1) | <0.001 |
HTA, n (%) | 210 (90.9) | 169 (92.3) | 0.373 |
DM, n (%) | 14 (6.1) | 28 (15.4) | 0.002 |
Heart failure, n (%) | 119 (51.5) | 14 (7.7) | <0.001 |
Dyslipidemia, n (%) | 112 (48.5) | 35 (19.2) | <0.001 |
Atrial fibrillation, n (%) | 28 (12.1) | 0 (0.0) | <0.001 |
Obesity, n (%) | 77 (33.3) | 42 (23.1) | 0.014 |
PP ≥ 65 mmHg | 28 (12.1) | 14 (7.7) | 0.093 |
Venous thromboembolic disease, n (%) | 14 (6.1) | 7 (3.8) | 0.216 |
BB, n (%) | 112 (48.5) | 35 (19.2) | <0.001 |
ARA II, n (%) | 182 (78.8) | 105 (57.7) | <0.001 |
Calcium blocker, n (%) | 91 (39.4) | 77 (42.3) | 0.309 |
BMI, Kg/m2 | 28.9 ± 4.3 | 27.7 ± 4.3 | 0.007 |
SBP, mmHg | 132.4 ± 20.4 | 129.3 ± 15.1 | 0.085 |
DBP, mmHg | 79.7 ± 16.1 | 78.2 ± 13.0 | 0.319 |
MBP, mmHg | 97.3 ± 16.5 | 95.2 ± 11.7 | 0.164 |
PP, mmHg | 52.7 ± 13.3 | 51.0 ± 15.1 | 0.236 |
HR, cbm | 84.0 ± 22.6 | 74.8 ± 15.3 | <0.001 |
CT | 154.3 ± 47.0 | 165.2 ± 40.0 | 0.074 |
LDL-c | 124.7 (91.0 - 158.4) | 77.0 (71.0 - 79.0) | 0.002 |
TG | 81.9 (79.1 - 81.9) | 85.3 (43.6 - 51.3) | 0.397 |
HDL-c | 45.6 (41.6 - 46.5) | 47.5 (43.6 - 51.3) | 0.241 |
Creatinine | 1.1 (0.98 - 1.21) | 0.81 (0.62 - 1.0) | 0.001 |
ProBNP | 100.0 (38.0 - 716.0) | 37.0 (15.0 - 59.0) | 0.001 |
Troponin | 9.9 (9.1 - 11.5) | 0.76 (0.01 - 1.5) | <0.001 |